全文获取类型
收费全文 | 3104篇 |
免费 | 189篇 |
国内免费 | 20篇 |
专业分类
耳鼻咽喉 | 58篇 |
儿科学 | 93篇 |
妇产科学 | 74篇 |
基础医学 | 276篇 |
口腔科学 | 63篇 |
临床医学 | 254篇 |
内科学 | 648篇 |
皮肤病学 | 46篇 |
神经病学 | 139篇 |
特种医学 | 107篇 |
外科学 | 594篇 |
综合类 | 58篇 |
一般理论 | 7篇 |
预防医学 | 308篇 |
眼科学 | 140篇 |
药学 | 296篇 |
中国医学 | 25篇 |
肿瘤学 | 127篇 |
出版年
2023年 | 33篇 |
2022年 | 42篇 |
2021年 | 87篇 |
2020年 | 83篇 |
2019年 | 127篇 |
2018年 | 146篇 |
2017年 | 114篇 |
2016年 | 130篇 |
2015年 | 120篇 |
2014年 | 163篇 |
2013年 | 226篇 |
2012年 | 284篇 |
2011年 | 288篇 |
2010年 | 153篇 |
2009年 | 146篇 |
2008年 | 205篇 |
2007年 | 200篇 |
2006年 | 181篇 |
2005年 | 133篇 |
2004年 | 107篇 |
2003年 | 95篇 |
2002年 | 71篇 |
2001年 | 34篇 |
2000年 | 15篇 |
1999年 | 12篇 |
1998年 | 12篇 |
1997年 | 14篇 |
1996年 | 12篇 |
1995年 | 10篇 |
1994年 | 8篇 |
1993年 | 5篇 |
1992年 | 7篇 |
1991年 | 5篇 |
1990年 | 4篇 |
1989年 | 5篇 |
1987年 | 5篇 |
1986年 | 2篇 |
1985年 | 3篇 |
1981年 | 1篇 |
1980年 | 2篇 |
1979年 | 2篇 |
1978年 | 2篇 |
1977年 | 1篇 |
1975年 | 5篇 |
1973年 | 2篇 |
1972年 | 1篇 |
1971年 | 2篇 |
1968年 | 2篇 |
1966年 | 2篇 |
1963年 | 1篇 |
排序方式: 共有3313条查询结果,搜索用时 31 毫秒
1.
2.
3.
4.
5.
6.
Psychometric evaluation of the Persian version of the Type 2 Diabetes and Health Promotion Scale (T2DHPS): a diabetes‐specific measure of lifestyle 下载免费PDF全文
7.
8.
Maryam Sahlolbei Mohsen Dehghani Behghat Kheiri yeghane azar Somayeh Vafaei G Roviello Alberto D’Angelo 《International reviews of immunology》2020,39(5):223-232
AbstractOne of the cutting edge techniques for treating cancer is the use of the patient’s immune system to prevail cancerous disease. The versatility of the chimeric antigen receptor (CAR) T-cell approach in conjugation with promising treatments in haematological cancer has led to countless cases of research literature for the treatment of solid cancer. A systematic search of online databases as well as gray literature and reference lists of retrieved studies were carried out up to March 2019 to identify experimental animal studies that investigated the antigens targeted by CAR T-cell for pancreatic cancer treatment. Studies were evaluated for methodological quality using the SYstematic Review Center for Laboratory Animal Experimentation bias risk tool (SYRCLE’s ROB tool). Pooled cytotoxicity ratio/percentage and 95% confidence intervals were calculated using the inverse-variance method while random-effects meta-analysis was used, taking into account conceptual heterogeneity. Heterogeneity was assessed with the Cochran Q statistic and quantified with the I2 statistic using Stata 13.0. Of the 485 identified studies, 56 were reviewed in-depth with 16 preclinical animal studies eligible for inclusion in the systematic review and 11 studies included in our meta-analysis. CAR immunotherapy significantly increased the cytotoxicity assay (percentage: 65%; 95% CI: 46%, 82%). There were no evidence for significant heterogeneity across studies [P?=?0.38 (Q statistics), I2?=?7.14%] and for publication bias. The quality assessment of included studies revealed that the evidence was moderate to low quality and none of studies was judged as having a low risk of bias across all domains. CAR T-cell therapy is effective for pancreatic cancer treatment in preclinical animal studies. Further high-quality studies are needed to confirm our finding and a standard approach of this type of studies is necessary according to our assessment. 相似文献
9.
Shahrzad Ghafary Roshanak Ghobadian Mohammad Mahdavi Hamid Nadri Alireza Moradi Tahmineh Akbarzadeh Zahra Najafi Mohammad Sharifzadeh Najmeh Edraki Farshad Homayouni Moghadam Mohsen Amini 《Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences》2020,28(2):463
BackgroundAcetylcholine deficiencies in hippocampus and cortex, aggregation of β-amyloid, and β-secretase over activity have been introduced as main reasons in pathogenesis of Alzheimer’s disease.MethodsColorimetric Ellman’s method was used for determination of IC50 value in AChE and BChE inhibitory activity. The kinetic studies, neuroprotective and β-secretase inhibitory activities, evaluation of inhibitory potency on β-amyloid (Aβ) aggregations induced by AChE, and docking study were performed for prediction of the mechanism of action.Result and discussionA new series of cinnamic acids-tryptamine hybrid was designed, synthesized, and evaluated as dual cholinesterase inhibitors. These compounds demonstrated in-vitro inhibitory activities against acetyl cholinesterase (AChE) and butyryl cholinesterase (BChE). Among of these synthesized compounds, (E)-N-(2-(1H-indol-3-yl)ethyl)-3-(3,4-dimethoxyphenyl)acrylamide (5q) demonstrated the most potent AChE inhibitory activity (IC50 = 11.51 μM) and (E)-N-(2-(1H-indol-3-yl)ethyl)-3-(2-chlorophenyl)acrylamide (5b) were the best anti-BChE (IC50 = 1.95 μM) compounds. In addition, the molecular modeling and kinetic studies depicted 5q and 5b were mixed type inhibitor and bound with both the peripheral anionic site (PAS) and catalytic sites (CAS) of AChE and BChE. Moreover, compound 5q showed mild neuroprotective in PC12 cell line and weak β-secretase inhibitory activities. This compound also inhibited aggregation of β-amyloid (Aβ) in self-induced peptide aggregation test at concentration of 10 μM.ConclusionIt is worth noting that both the kinetic study and the molecular modeling of 5q and 5b depicted that these compounds simultaneously interacted with both the catalytic active site and the peripheral anionic site of AChE and BChE. These findings match with those resulted data from the enzyme inhibition assay. Graphical abstractOpen in a separate windowA new series of cinnamic-derived acids-tryptamine hybrid derivatives were designed, synthesized and evaluated as butyrylcholinesterase (BChE) and acetylcholinesterase (AChE) inhibitors and neuroprotective agents. Compound 5b and 5q, as the more potent compounds, interacted with both the peripheral site and the choline binding site having mixed type inhibition. Results suggested that derivatives have a therapeutic potential for the treatment of AD.Electronic supplementary materialThe online version of this article (10.1007/s40199-020-00346-9) contains supplementary material, which is available to authorized users. 相似文献
10.
Novel cinnamic acid–tryptamine hybrids as potent butyrylcholinesterase inhibitors: Synthesis,biological evaluation,and docking study 下载免费PDF全文